Masimo Founder and CEO Joe Kiani to Speak on AI at Global Patient Safety Summit in Chile
Business Wire (Tue, 16-Apr 8:00 AM ET)
Stifel upgrades Masimo to buy, sees room for share price appreciation
Seeking Alpha News (Mon, 15-Apr 2:36 PM ET)
Buy Rating Affirmed for Masimo: Strategic Developments and Positive Outlook Signal Growth
TipRanks (Mon, 15-Apr 4:55 AM ET)
Business Wire (Mon, 1-Apr 8:00 AM ET)
Politan Nominates Two Independent Candidates for Masimo Board
Business Wire (Mon, 25-Mar 7:00 AM ET)
Business Wire (Fri, 22-Mar 4:05 PM ET)
Globe Newswire (Thu, 21-Mar 9:00 PM ET)
Masimo Named One of Fast Company's Most Innovative Companies in North America
Business Wire (Tue, 19-Mar 2:36 PM ET)
Masimo Celebrates Multiple Wins at the iF DESIGN AWARDS 2024
Business Wire (Thu, 7-Mar 8:00 AM ET)
Masimo to Present in 45th Annual Raymond James Institutional Investors Conference
Business Wire (Mon, 4-Mar 8:30 AM ET)
Masimo Corp is a global technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies.
Masimo trades on the NASDAQ stock market under the symbol MASI.
As of April 19, 2024, MASI stock price declined to $134.77 with 321,601 million shares trading.
MASI has a beta of 0.93, meaning it tends to be less sensitive to market movements. MASI has a correlation of 0.06 to the broad based SPY ETF.
MASI has a market cap of $7.44 billion. This is considered a Mid Cap stock.
Last quarter Masimo reported $549 million in Revenue and $1.25 earnings per share. This beat revenue expectation by $4 million and exceeded earnings estimates by $.39.
In the last 3 years, MASI stock traded as high as $305.21 and as low as $75.22.
The top ETF exchange traded funds that MASI belongs to (by Net Assets): VTI, IJH, VB, VBK, VXF.
MASI has underperformed the market in the last year with a price return of -29.8% while the SPY ETF gained +21.2%. However, in the short term, MASI had mixed performance relative to the market. It has outperformed in the last 3 months, returning +10.1% vs +4.3% return in SPY. But in the last 2 weeks, MASI shares have been beat by the market, returning -3.9% compared to an SPY return of -3.5%.
MASI support price is $132.91 and resistance is $138.93 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MASI stock will trade within this expected range on the day.